Core Viewpoint - Park Ha (PHH) experienced a significant stock price increase of 17.76%, reaching $0.776 per share, with a total market capitalization of $20.46 million as of August 5 [1] Financial Performance - As of October 31, 2024, Park Ha reported total revenue of 2.38 million RMB, reflecting a year-on-year decrease of 3.14% [1] - The net profit attributable to the parent company was 478,600 RMB, showing a substantial year-on-year decline of 43.83% [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct selling skincare products, and promoting franchise alliances [1] - The "Park Ha" brand, established in 2016, aims to provide solutions for problematic skin and opened its first store in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, with 41 and 36 operating under the "Park Ha" name [1] - In 2022, the company had a total of 49 franchisees [1]